Journal
CELL METABOLISM
Volume 34, Issue 7, Pages 1042-+Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2022.05.007
Keywords
-
Categories
Funding
- National Institutes of Health [R35GM122465, R01DK119795, T32DK007568-30S1, R01GM087964, R01AA029124]
- Department of Defense (DOD) [W81XWH1910676]
- National Research Foundation of Korea [2021R1A6A3A-14039681, 2021R1A6A3A-14039132]
- AASLD Foundation Pinnacle Research Award in Liver Disease
- Edward Mallinckrodt, Jr. Foundation Award
- U.S. Department of Defense (DOD) [W81XWH1910676] Funding Source: U.S. Department of Defense (DOD)
Ask authors/readers for more resources
Dietary fructose, especially in the context of a high-fat western diet, has been linked to type 2 diabetes. This study found that dietary fat enhances fructose metabolism in the small intestine, releasing glycerate into the blood. High systemic levels of glycerate cause damage to pancreatic islet cells and reduce islet sizes, leading to glucose intolerance.
Dietary fructose, especially in the context of a high-fat western diet, has been linked to type 2 diabetes. Although the effect of fructose on liver metabolism has been extensively studied, a significant portion of the fructose is first metabolized in the small intestine. Here, we report that dietary fat enhances intestinal fruc-tose metabolism, which releases glycerate into the blood. Chronic high systemic glycerate levels induce glucose intolerance by slowly damaging pancreatic islet cells and reducing islet sizes. Our findings provide a link between dietary fructose and diabetes that is modulated by dietary fat.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available